Heart health after menopause
This is not medical advice — it is general information based on what you searched for that may help.
General information based on published sources and the symptoms you searched for. This isn't medical or legal advice, a diagnosis or a treatment plan. Please consult a doctor about your own symptoms. If your symptoms are severe or sudden, seek urgent care.
Evidence:Strong evidence
Cardiovascular risk rises for everyone with age, but the menopause transition marks a notable inflection point. A 2026 narrative review describes the transition as accompanied by substantially increased cardiovascular disease risk, which intensifies after age 50 — the proportion of women at intermediate-to-high cardiovascular risk nearly doubles between ages 51 and 55. The same review notes that hot flashes and night sweats themselves correlate with increased cardiovascular risk, not just with discomfort.
Why HRT isn't used to prevent heart disease
This surprises a lot of people: NICE guideline NG23 recommends not offering combined or oestrogen-only HRT for primary or secondary prevention of cardiovascular disease. Preventing heart disease and treating menopause symptoms are two different clinical questions, even though both involve the same medication.
At the same time, NICE notes that coronary heart disease risk does not increase with combined or estrogen-only HRT in women with no personal history of it — so taking HRT for symptom relief isn't understood to raise CHD risk on its own, even though it isn't prescribed to lower it either.
The "timing hypothesis"
Research on HRT and cardiovascular outcomes has converged on what's called the timing hypothesis: starting HRT within 10 years of menopause onset, or before age 60, may be associated with a more favorable cardiovascular profile, while starting later may carry more risk. This is the same "timing window" referenced throughout our HRT guidance — it isn't a separate rule, just the same principle applied specifically to cardiovascular outcomes.
Outcomes also vary by formulation, route, and individual risk factors. Route matters concretely for stroke and clotting: stroke risk is unlikely to rise with transdermal estrogen but does rise with oral estrogen, and the same pattern holds for blood clots — see HRT and blood clot risk for the full picture.
Even with this research, the 2026 review is clear that significant uncertainties persist, due to how varied the existing trials are and how underrepresented some populations remain in the research.
What actually helps protect your heart
The modern approach favors individualized care: knowing your personal risk factors (blood pressure, cholesterol, weight, family history, smoking), choosing HRT formulation and route with cardiovascular safety in mind if you use it, and standard cardiovascular prevention — physical activity, discussed in our exercise evidence guide, being one well-supported piece of that.
Prepare for your appointment
Log blood pressure readings, symptoms, and questions in our private symptom tracker before your next check-up.
- Given my personal cardiovascular risk factors, does the timing hypothesis change how we think about HRT for my symptoms?
- What cardiovascular screening (blood pressure, cholesterol, other risk factors) should I have now that I've reached menopause?
Where are you right now?
Still tracking
Not sure if your symptoms fit? Start tracking your daily patterns.
Log and spot your patterns with the symptom checklist →Ready to talk to a doctor
Have an upcoming appointment? Bring structured questions and your history.
Prepare your 10-minute doctor appointment questions →Already on treatment
Evaluating your response or wondering what to adjust next?
Explore evidence-graded treatment and lifestyle options →Questions people ask
Does menopause itself cause heart disease?
Menopause doesn't cause heart disease directly, but cardiovascular risk rises significantly around this time of life. A 2026 review notes the proportion of women at intermediate-to-high cardiovascular risk nearly doubles between ages 51 and 55, and that risk is linked to aging, the loss of estrogen's effects on blood vessels, and other factors that tend to cluster at midlife (blood pressure, cholesterol, weight).
Can I take HRT to protect my heart?
No — NICE guidance specifically recommends against using HRT for primary or secondary prevention of cardiovascular disease. That said, NICE also notes coronary heart disease risk does not increase with HRT in women with no personal history of it, and the 'timing hypothesis' suggests starting HRT earlier (within 10 years of menopause or before 60) for symptom relief may carry a different cardiovascular profile than starting it later — these are two separate questions.
Related pages
References
- Khalifey HT, Mahereen R, Adwan R et al.. The impact of hormone replacement therapy on cardiovascular health in postmenopausal women: a narrative review. Frontiers in Reproductive Health, 2026.
- Menopause: identification and management (NG23), Recommendations. National Institute for Health and Care Excellence (UK), 2026.
Change log
- : Published evidence guide on heart health after menopause